Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL—Response

We thank Adams and colleagues for their interest in our research (1) on the prognostic value of baseline total metabolic tumor volume (TMTV) combined with molecular data in patients with diffuse large B-cell lymphoma (DLBCL). They give us the opportunity to discuss TMTV and clinical prognostic